Caffeine Content and Sleep Implications of CHAGEE Milk Tea: A Back Iodometric Titration Study

Zhixin He; Xintong Lai

doi:10.54097/dr52sa73

Authors

Zhixin He
Xintong Lai

DOI:

https://doi.org/10.54097/dr52sa73

Keywords:

Caffeine, Milk Tea, Back Iodometric Titration, Sleep Quality, Quantitative Analysis

Abstract

Caffeine is a potent psychoactive compound that occurs naturally in some drinks, such as tea, coffee, and milk tea, that works to either improve alertness or encourage sleep. This research aims to present the caffeine levels in CHAGEE milk tea and indicate potential outcomes on sleep. The study used the much-esteemed back iodometric titration as the approach of analysis due to its validity and reliability in science. The measured levels of caffeine in CHAGEE were higher than predicted, and caffeine levels might collectively be equivalent to or higher than a full cup of traditional tea. The consumption of CHAGEE has the potential for too much caffeine consumption from the beverage, thus negatively affecting the quality of sleep. This research contains useful information for consumers about making healthy choices in beverages that they may consume, and indicates features for future research to expand food safety and nutrition aspects. Additionally, this research could assist product developers in improving product formulas and labeling in a way that supports public health awareness from consumption. Future studies may also explore the caffeine interaction with other substances in milk tea and their combined biological effects.

Downloads

Download data is not yet available.

References

[1] Roehrs, T., & Roth, T. (2008). Caffeine: Sleep and daytime sleepiness. _Sleep Medicine Reviews_, _ 12 _(2), 153-162. https://doi.org/10.1016/j.smrv.2007.07.004.

[2] Reyes, C. M., & Cornelis, M. C. (2018). Caffeine in the Diet: Country-Level Consumption and Guidelines. Nutrients, 10(11), 1772.https://doi.org/10.3390/nu10111772.

[3] The Relationship Between Caffeine Consumption and Self-Reported Sleep Quality Among Healthcare Professionals,14.

[4] Willson, C. (2018). The clinical toxicology of caffeine: A review and case study. _Toxicology Reports_, _5_, 1140-1152. https://doi.org/10.1016/j.toxrep.2018.10.001.

[5] Ogbeide, U. M., Irene, D. E., & Okeri, H. A. (2021). Assessment of pH, titratable acidity, and caffeine content of some brands of energy drinks. Journal of Science and Practice of Pharmacy, 8(1), 441-446. https://doi.org/10.47227/jsppharm.v8i1.4.

[6] Pietzke, M., Meiser, J., & Vazquez, A. (2020). Formate metabolism in health and disease. _Molecular Metabolism_, _33_, 23-37. https://doi.org/10.1016/j.molmet.2019.06.010.

[7] de Souza, J. G., Del Coso, J., Fonseca, F. S., Silva, B. V. C., de Souza, D. B., da Silva Gianoni, R. L., Filip-Stachnik, A., Serrao, J. C., & Claudino, J. G. (2022). Risk or benefit? Side effects of caffeine supplementation in sport: a systematic review. European journal of nutrition, 61(8), 3823-3834. https://doi.org/10.1007/s00394-022-02874-3.

[8] Reddy, V. S., Shiva, S., Manikantan, S., & Ramakrishna, S. (2024). Pharmacology of caffeine and its effects on the human body. _European Journal of Medicinal Chemistry Reports_, _10_, Article 100138. https://doi.org/10.1016/j.ejmcr.2024.100138.

[9] Roshan, M. H., Tambo, A., & Pace, N. P. (2016). Potential Role of Caffeine in the Treatment of Parkinson's Disease. The open neurology journal, 10, 42-58. https://doi.org/10. 2174/ 1874205X01 6100 10042.

[10] Leitzmann, M. F., Stampfer, M. J., Willett, W. C., Spiegelman, D., Colditz, G. A., & Giovannucci, E. L. (2002). Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology, 123(6), 1823-1830. https://doi.org/10.1053/gast.2002.37054.

[11] Ribeiro, J. A., & Sebastião, A. M. (2010). Caffeine and adenosine. Journal of Alzheimer's disease : JAD, 20 Suppl 1, S3–S15. https://doi.org/10.3233/JAD-2010-1379.

[12] Reichert, C. F., Deboer, T., & Landolt, H. P. (2022). Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives. Journal of sleep research, 31(4), e13597. https:// doi.org/ 10.1111/ jsr. 13597.

[13] Benowitz N. L. (1990). Clinical pharmacology of caffeine. Annual review of medicine, 41, 277-288. https:// doi.org/10.1146/annurev.me.41.020190.001425.

[14] Song, X., Kirtipal, N., Lee, S., Maly, P., & Bharadwaj, S. (2023). Current therapeutic targets and multifaceted physiological impacts of caffeine. Phytotherapy research: PTR, 37(12), 5558-5598. https:// doi. org/10.1002/ptr.8000.

[15] Institute of Medicine (US) Committee on Military Nutrition Research. (2001). Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. National Academies Press (US).

[16] Suhail, M., Fang, C. W., Chiu, I. H., Khan, A., Wu, Y. C., Lin, I. L., Tsai, M. J., & Wu, P. C. (2023). Synthesis and Evaluation of Alginate-Based Nanogels as Sustained Drug Carriers for Caffeine. ACS omega, 8(26), 23991-24002. https://doi.org/10.1021/acsomega.3c02699.

[17] Nehlig A. (2018). Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption. Pharmacological reviews, 70(2), 384-411.https://doi.org/10.1124/pr.117.014407.

[18] Arnaud M. J. (2011). Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handbook of experimental pharmacology, (200), 33-91. https://doi.org/10.1007/978-3-642-13443-2_3.

[19] Guest, N., Corey, P., Vescovi, J., & El-Sohemy, A. (2018). Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes. Medicine and science in sports and exercise, 50(8), 1570-1578. https:// doi. org/ 10.1249/MSS.0000000000001596.

[20] Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., & Welsh, B. T. (2016). Caffeine: Friend or Foe?. Annual review of food science and technology, 7, 117-137. https://doi.org/ 10. 1146/ annurev-food-041715-033243.

[21] Uehara, S., Uno, Y., Inoue, T., Suzuki, T., Utoh, M., Sasaki, E., & Yamazaki, H. (2016). Caffeine 7-N-demethylation and C-8-oxidation mediated by liver microsomal cytochrome P450 enzymes in common marmosets. Xenobiotica; the fate of foreign compounds in biological systems, 46(7), 573-578. https:// doi. org/10.3109/00498254.2015.1096980.

[22] Shan, L., Wang, F., Zhai, D., Meng, X., Liu, J., & Lv, X. (2022). Caffeine in liver diseases: Pharmacology and toxicology. Frontiers in pharmacology, 13, 1030173.https://doi.org/10.3389/fphar.2022.1030173.

[23] Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G., & Garattini, S. (1982). Caffeine disposition after oral doses. Clinical Pharmacology and Therapeutics, 32(1), 98-106. https://doi.org/ 10.1038/ clpt. 1982.132.

[24] Wallrabe, C. A. (1931). Apotheker-Zeitung, 46, 341–343. Abstracted in Chemical Abstracts, 25, 3433.

[25] Fritz, J. S. (1950). A note on the titration of caffeine in pharmaceutical preparations. Analytical Chemistry, 22(8), 1028–1029. https://doi.org/10.1021/ac60044a017.

[26] Fajara, B. E. P., & Susanti, H. (2017). HPLC determination of caffeine in coffee beverage. IOP Conference Series: Materials Science and Engineering, 259(1), 012011. https://doi.org/10.1088/1757-899X/259/1/012011.

[27] Ahmad Bhavani, S., Fong, S. S., & Mohamad Ibrahim, M. N. (2015). Spectrophotometric Analysis of Caffeine. International journal of analytical chemistry, 2015, 170239. https://doi.org/ 10.1155/ 2015/ 170239.

[28] Weina, M., Szymczycha-Madeja, A., & Pohl, P. (2023). Novel ICP-OES-Based Method for the Reliable Determination of the Total Content of 15 Elements in Yerba Mate Drinks along with the Determination of Caffeine and the In Vitro Bioaccessibility of the Compounds. Molecules (Basel, Switzerland), 28(8), 3374. https://doi.org/10.3390/molecules28083374.

[29] Vandeponseele, A., Draye, M., Piot, C., & Chatel, G. (2021). Study of Influential Parameters of the Caffeine Extraction from Spent Coffee Grounds: From Brewing Coffee Method to the Waste Treatment Conditions. Clean Technologies, 3(2), 335-350. https://doi.org/10.3390/cleantechnol3020019.